SCHEMBL15323760

SCHEMBL15323760

CNc1c(N)cc(C(=O)OC)c2c1OCCO2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.54
ALDH1A1 P00352 6/20 0.54
HTR4 Q13639 5/20 0.42
GAA P10253 5/20 0.41
HSD17B10 Q99714 4/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
HTR1A P08908 1/20 0.40
CHRM5 P08912 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
CHRM3 P20309 1/20 0.40
DRD5 P21918 1/20 0.40
SLC6A2 P23975 1/20 0.40
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15324655 0.85 KDM4E (0.50) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL7398883 0.83 KDM4E (0.58) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL13603003 0.81 KDM4E (0.55) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL15322464 0.79 PDGFRB (0.43) KDM4EALDH1A1HTR4MAPTHPGD
SCHEMBL29054678 0.76 KDM4E (0.53) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL30507871 0.76 KDM4E (0.53) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL7402316 0.75 ALDH1A1 (0.55) KDM4EALDH1A1HTR4GAAHSD17B10
SCHEMBL14810489 0.75 HTR4 (0.58) KDM4EALDH1A1HTR4GAACHRM2
SCHEMBL2698798 0.74 KDM4E (0.40) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL6848305 0.73 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed